Capsular types and predicting patient outcomes in pneumococcal bacteremia

Clinical Infectious Diseases

Volumn 45, Issue 1, 2007, Pages 52-54

  Garau, Javier ^a,b   Calbo, Esther ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL MÚTUA DE TERRASSA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGENICITY; BACTEREMIA; BACTERIAL MEMBRANE; NOTE; PRIORITY JOURNAL; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

BACTEREMIA; HUMANS; PNEUMOCOCCAL INFECTIONS; POLYSACCHARIDES; PROGNOSIS; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; VIRULENCE;

EID: 34250845509     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/518576     Document Type: Note

References (25)

1. Dochez AR, OT Avery. The elaboration of specific soluble substance by pneumococcus during growth. J Exp Med 1917; 26:477-93.
2. Avery OT, Heidelberger M. Immunological relationships of cell constituents of pneumococcus. J Exp Med 1925; 42:367-76.
3. Kamerling IP. Pneumococcal polysaccharides: a chemical view. In: Tomasz A, ed. Streptococcus pneumoniae, molecular biology and mechanisms of disease. New York: Mary Ann Liebert, 2000:81-114.
4. Jones C. Capsular polysaccharides from Neisseria meningitidis and Streptococcus pneumoniae. Carbohydrates in Europe 1998; 21:10-6.
5. Henrichsen J. Six newly recognized types of Streptococcus pneumoniae. J Clin Microbiol 1995; 33:2759-62.
6. Guckian JC, Christensen GD, Fine DP. The role of opsonins in recovery from experimental pneumococcal pneumonia. J Infect Dis 1980; 142:175-90.
7. Fine DP. Pneumococcal type-associated variability in alternate complement pathway activation. Infect Immun 1975; 12:772-8.
8. Hostetter MK. Serotypic variations among virulent pneumococci in deposition and degradation of covalently bound C3b: implications for phagocytosis and antibody production. J Infect Dis 1986; 153:682-93.
9. Henriques B, Kalin M, Ortqvist A, et al. Molecular epidemiology of Streptococcus pneumoniae causing invasive disease in five countries. J Infect Dis 2000; 182:833-9.
10. Finland M, Barnes MW. Changes in occurrence of capsular serotypes of Streptococcus pneumoniae at Boston City Hospital during selected years between 1935 and 1974. J Clin Microbiol 1977; 5:154-66.
11. Austrian R, Gold J. Pneumococcal bacteremia with special reference to bacteremic pneumococcal pneumonia. Ann Intern Med 1964; 60:759-76.
12. Ortqvist A, Kalin M, Julander I, Mufson M. Deaths in bacteremic pneumococcal pneumonia: a comparison of two populations - Huntington, West Virginia, and Stockholm, Sweden. Chest 1993; 103:710-6.
13. Gransden WR, Eykyn SJ, Phillips I. Pneumococcal bacteraemia: 325 episodes diagnosed at St. Thomas's Hospital. Br Med J (Clin Res Ed) 1985; 290:505-8.
14. Macfarlane JT, Finch RG, Ward MJ, Macrae AD. Hospital study of adult community-acquired pneumonia. Lancet 1982; 2:255-8.
15. Martens P, Worm SW, Lundgren B, Konradsen HB, Benfield T. Serotype-specific mortality from invasive Streptococcus pneumoniae disease revisited. BMC Infect Dis 2004; 4:21 .
16. Sjostrom K, Spindler C, Ortqvist A, et al. Clonal and capsular types decide whether pneumococci will act as primary or opportunistic pathogens. Clin Infect Dis 2006; 42:451-9.
17. Alanee SRJ, L McGee, D Jackson et al. Association of serotypes of Streptococcus aureus with disease severity and outcome in adults: an international study. Clin Infect Dis 2007; 45:46-51 (in this issue).
18. Kelly T, JP Dillard, J Yother. Effect of genetic switching of capsular type on virulence of Streptococcus pneumoniae. Infect Immun 1994; 62:1813-9.
19. Sandgren A, Sjostrom K, Olsson-Liljequist B, et al. Effect of clonal and serotype specific properties on the invasive capacity of Streptococcus pneumoniae. J Infect Dis 2004; 189:785-96.
20. Mizrachi Nebenzahl Y, Porat N, Lifshitz S, et al. Virulence of Streptococcus pneumoniae may be determined independently of capsular polysaccharide. FEMS Microbiol Lett 2004; 233:147-52.
21. Tuomanen E, Tomasz A, Hengstler B, Zak O. The relative role of bacterial cell wall and capsule in the induction of inflammation in pneumococcal meningitis. J Infect Dis 1985; 151:535-40.
22. Houldsworth SP, Andrew PW, Mitchell TJ. Pneumolysin stimulates production of tumor necrosis factor alpha and interleukine 1 beta by human mononuclear phagocytes. Infect Immun 1994; 62:1501-3.
23. Gillespie SH, Balakrishnan I. Pathogenesis of pneumococcal infection. J Med Microbiol 2000; 49:1057-67.
24. Barocchi MA, Ries J, Zogaj X, et al. A pneumococcal pilus influences virulence and host inflammatory responses. Proc Natl Acad Sci U S A 2006; 103:2857-62.
25. Hava DL, CJ Hemsley, Camill AI. Transcriptional regulation in Streptococcus pneumoniae rlrA pathogenicity islet by RlrA. J Bacteriol 2003; 185:413-21.